Predictive Oncology (NASDAQ:AGPU) Announces Quarterly Earnings Results

Predictive Oncology (NASDAQ:AGPU) issued its quarterly earnings data on Tuesday. The company reported $122.75 earnings per share for the quarter, FiscalAI reports. The business had revenue of $0.01 million during the quarter.

Predictive Oncology Price Performance

Shares of NASDAQ:AGPU traded up $0.15 during trading on Tuesday, reaching $1.62. 28,563 shares of the company traded hands, compared to its average volume of 40,164. The company has a market capitalization of $5.49 million, a price-to-earnings ratio of -0.12 and a beta of 1.40. Predictive Oncology has a 52 week low of $1.03 and a 52 week high of $32.10. The business’s 50 day moving average price is $2.13.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings assumed coverage on shares of Predictive Oncology in a research report on Monday, January 26th. They set a “sell (e+)” rating on the stock. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About Predictive Oncology

Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.

Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.